Toshitaka Shiono

Title: The Innovations of Toshitaka Shiono

Introduction

Toshitaka Shiono is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of peptides that interact with epidermal growth factor receptors (EGFR). His work has implications for various therapeutic applications, showcasing the potential of peptide-based treatments.

Latest Patents

Toshitaka Shiono holds a patent for an EGFR-binding peptide. This invention provides a substance capable of binding to EGFR specifically with a high affinity. The patent describes a peptide that contains at least an amino acid sequence represented by specific formulas and is composed of 12 to 50 amino acids. This innovation is crucial for developing pharmaceutical agents that target EGFR, which is often implicated in various cancers.

Career Highlights

Shiono is associated with Hoya Corporation, a company known for its advancements in optical and healthcare technologies. His role at Hoya Corporation allows him to leverage his expertise in peptide design and development, contributing to the company's innovative projects.

Collaborations

Toshitaka Shiono has collaborated with notable colleagues, including Yusuke Iimori and Mizue Yamagata. These collaborations enhance the research and development efforts within his team, fostering an environment of innovation and creativity.

Conclusion

Toshitaka Shiono's work exemplifies the intersection of biotechnology and pharmaceutical development. His contributions, particularly in the area of EGFR-binding peptides, highlight the importance of innovation in addressing medical challenges. His career continues to inspire future advancements in the field.